Evaluation of antiarrhythmic drug efficacy in patients with an ICD. Unlimited potential or replete with complexity and problems?

C. M. Pratt, A. J. Camm, J. T. Bigger, G. Breithardt, R. W F Campbell, A. E. Epstein, L. J. Kappenberger, K. H. Kuck, S. Pocock, S. Saksena, A. L. Waldo

Research output: Contribution to journalArticle

5 Scopus citations

Abstract

A report from a Study group, proposed by A. J. Camm, London, of the Working Groups on Arrhythmias and Cardiac Pacing of the European Society of Cardiology; co-sponsored by the North American Society of Pacing and Electrophysiology. The Study Group was convened on 29 August 1997 at Saltsjobaden, near Stockholm. The meeting was chaired by A. J. Camm, London, and C. M. Pratt, Houston. Based on the presentation and discussions, a first draft of the documents was prepared by C. Pratt and J. Camm which was then circulated to all members three times for their review. All members of the Study Group approved the final manuscript. This report represents the opinion of the members of this Study Group and does not necessarily reflect the official position of either society. The meeting of the Study Group was made posssible by unrestricted educational grants from Medtronic, Guidant, Proctor and Gamble, Berlex and Sanofi. Also, presented, in part, at the Cardio-Renal Drugs Advisory Board meeting of the Food and Drug Administration, Bethesda, Maryland, on 30 April 1999.

Original languageEnglish (US)
Pages (from-to)1538-1552
Number of pages15
JournalEuropean heart journal
Volume20
Issue number21
DOIs
StatePublished - Nov 1999
Externally publishedYes

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Fingerprint Dive into the research topics of 'Evaluation of antiarrhythmic drug efficacy in patients with an ICD. Unlimited potential or replete with complexity and problems?'. Together they form a unique fingerprint.

Cite this